Close
Digital Health & Ai Innovation summit 2026
APE 2026

3D test for diagnosing malignant melanoma

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Nada to Capture Clinical Notes from...

PureHealth has commenced the pilot phase of Nada, which...

Real-Time Data Analytics from Connected Devices

Learn how continuous data streams from connected healthcare devices are transforming clinical practice through real-time analytics and actionable insights. Discover how clinicians leverage this continuous information flow to make timely decisions, enable preventive interventions, and personalize patient care based on comprehensive, current health data.

Wearable Sensors Driving Preventive Healthcare

Discover how advanced wearable sensor technology enables continuous health monitoring and early detection of warning signals. Learn how these devices empower both healthy individuals and at-risk populations to adopt proactive wellness approaches while supporting clinicians in preventive interventions before conditions become serious.

UK scientists have developed a 3D test for malignant melanoma that can identify problems not easily spotted in a standard two-dimensional view of the pattern on the skin. The researchers describe the technique in detail in the latest issue of the International Journal of Modelling, Identification and Control.

Malignant melanoma is one of the most aggressive and life-threatening skin cancers. During the last thirty years, incidence rates have increased more than any other cancers in the UK. Successful treatment relies on early diagnosis, so developing an automated scanning method that avoids the need to take biopsies is high on the research agenda.

Conventionally, a group of 2D skin measurements, the asymmetry, border, colour and diameter (ABCD) rules are commonly used to distinguish between malignancy and benign skin growths, but diagnostic accuracy is not convincing.

Now, Lyndon Smith and colleagues at the Machine Vision Laboratory, Bristol Institute of Technology, University of the West of England, Bristol have collaborated with Robert Warr of the Department of Plastic Surgery, at North Bristol NHS Trust, to develop a computer-assisted diagnosis system that could improve outcomes significantly. The system could quickly and automatically reveal changes in the 3D surface texture of skin that occur in malignant melanoma, which are much greater than in benign lesions, such as moles and freckles.

The team used a handheld six-light stereo device connected to a laptop computer to scan the skin’s surface. This device produces a 3D model of the skin texture patterns. The information is then analysed by the laptop, which compares it with patterns recorded from known cases of melanoma, used to "train" the software.

Preliminary studies on a sample set including 12 malignant melanomas and 34 benign lesions have given 91.7% sensitivity and 76.4% specificity from analysis of the 3D skin surface normals, the team says, which is more accurate than the results obtained from 2D pattern recognition.

Diagnosing malignant melanoma accurately is a very difficult task, the researchers say. However, based on these results a simple and non-invasive 3D test could improve the accuracy of diagnosis and so save lives but also avoid unnecessary surgery and treatment in people with benign conditions.

Latest stories

Related stories

Nada to Capture Clinical Notes from Medical Conversations

PureHealth has commenced the pilot phase of Nada, which...

Real-Time Data Analytics from Connected Devices

Learn how continuous data streams from connected healthcare devices are transforming clinical practice through real-time analytics and actionable insights. Discover how clinicians leverage this continuous information flow to make timely decisions, enable preventive interventions, and personalize patient care based on comprehensive, current health data.

Wearable Sensors Driving Preventive Healthcare

Discover how advanced wearable sensor technology enables continuous health monitoring and early detection of warning signals. Learn how these devices empower both healthy individuals and at-risk populations to adopt proactive wellness approaches while supporting clinicians in preventive interventions before conditions become serious.

Utilizing Real-World Evidence to Improve Trial Outcomes

Real-world evidence represents clinical data collected outside traditional controlled trial environments, derived from sources including electronic health records, insurance claims databases, disease registries, wearable devices, and patient-reported outcomes.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »